Steven A. Feldman

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Steven A. Feldman

Nov 18, 2024, 20:54 | Insight

Young patients with DIPG who respond well to the GD2 CAR-T cells

Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center,…

Nov 17, 2024, 07:41 | Drugs

Breakthrough GD2-CAR T-Cell Therapy Shows Promise for Pediatric Brain Cancer

GD2-CAR T-Cell Therapy Offers New Hope for Pediatric Brain Cancer The clinical study on GD2-CAR…

Nov 16, 2024, 15:56 | Insight

Michelle Monje: GD2-CAR T Cell Therapy for H3K27M+Diffuse Midline Gliomas

Michelle Monje, Professor of Pediatric Neuro-Oncology in the Department of Neurology and Neurological Sciences at…

Oct 11, 2024, 18:22 | Blog

Imagine giving your immune system’s cancer-fighting cells a powerful energy boost to take on tumors - Parker Institute for Cancer Immunotherapy

Yan Leyfman shared a post by Parker Institute for Cancer Immunotherapy on LinkedIn, adding: "Pioneering work…

All: 4 Posts: 1 - 100

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

'

King Charles III Hospitalized Following Side Effects from Cancer Treatment

'

Keith T. Flaherty has been elected as the AACR President-Elect for 2025-2026

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023